| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President &C.e.o.
3 companies
Capone Mark Christopher serves as a President &C.e.o. at MYGN and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 2 buys and 7 sells. Those positions are worth an estimated $15.0M at current prices.
The biggest single holding is MYGN (~$15.0M) as President &C.e.o.. The recent filings there lean toward selling, a net 297,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | MLAB Mesa Laboratories, Inc. | Director | Buy | 1,301 | $76.35 | $99,331.35 | +61.1% | +47.6% | - | |
| Aug 1, 2019 | MYGN Myriad Genetics Inc | President &C.e.o. | Sale+OE | 137,000 | $44.00 | $6,028,000.00 | -23.7% | - | - | |
| Jul 11, 2018 | MYGN Myriad Genetics Inc | President &C.e.o. | Sale+OE | 80,000 | $41.00 | $3,280,000.00 | -19.4% | - | - | |
| May 30, 2018 | MYGN Myriad Genetics Inc | President &C.e.o. | Sale+OE | 90,000 | $38.00 | $3,420,000.00 | -21.3% | - | - | |
| Aug 19, 2016 | MYGN Myriad Genetics Inc | President &C.e.o. | Buy | 10,000 | $21.24 | $212,400.00 | +7.4% | - | - |